Cancer

Items 41-50 of 79

per page
Set Descending Direction
  1. ITCH E3 Ligase TR-FRET Kit
    SBB-KF0035
    SBB-KF0035-KI011 Kit
    CHF 1'250.00
    ITCH E3 Ligase TR-FRET Kit
  2. LAIR2 (human) Matched Antibody Pair
    REV-31-1371-MK
    REV-31-1371-MK-KI011 Set
    CHF 629.00
    LAIR2 (human) Matched Antibody Pair
  3. MDM2 E3 Ligase TR-FRET Kit
    SBB-KF0030
    SBB-KF0030-KI011 Kit
    CHF 1'250.00
    MDM2 E3 Ligase TR-FRET Kit
  4. Nedd4 E3 Ligase TR-FRET Kit
    SBB-KF0056
    SBB-KF0056-KI011 Kit
    CHF 1'250.00
    % Signal to Background of Continuous Real-Time TR-FRET Parkin titration (autoubiquitination): Serial dilutions of Parkin W403A from 50nM to 3.125nM and 300nM wt Parkin were mixed with UBA1, UBE2D3 and trf-Ub (pS65) mix. Reactions were initiated wit
  5. Parkin E3 Ligase TR-FRET Kit
    SBB-KF0036
    SBB-KF0036-KI011 Kit
    CHF 1'250.00
    Parkin E3 Ligase TR-FRET Kit
  6. PD-1 (human) ELISA Kit
    AG-45B-0015
    AG-45B-0015-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  7. PD-L1 (human) ELISA Kit
    AG-45B-0016
    AG-45B-0016-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  8. Periostin (human) ELISA Kit
    AG-45B-0004
    AG-45B-0004-KI0196 wells
    CHF 580.00
    Periostin (human) ELISA Kit
  9. Periostin (human) Matched Pair Detection Set
    AG-46B-0005
    AG-46B-0005-KI011 Set
    CHF 750.00
    Reagents for 5 x 96-well plates
  10. Periostin (mouse) ELISA Kit
    AG-45B-0005
    AG-45B-0005-KI0196 wells
    CHF 510.00
    Standard curve

Items 41-50 of 79

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.